These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

525 related items for PubMed ID: 8201264

  • 21. Alterations in plasma complement levels after human ischemic stroke.
    Mocco J, Wilson DA, Komotar RJ, Sughrue ME, Coates K, Sacco RL, Elkind MS, Connolly ES.
    Neurosurgery; 2006 Jul; 59(1):28-33; discussion 28-33. PubMed ID: 16823297
    [Abstract] [Full Text] [Related]

  • 22. Platelet activation may explain the storage lesion in platelet concentrates.
    Bode AP.
    Blood Cells; 1990 Jul; 16(1):109-25; discussion 125-6. PubMed ID: 2190643
    [Abstract] [Full Text] [Related]

  • 23. Complexes between C1q and C3 or C4: novel and specific markers for classical complement pathway activation.
    Wouters D, Wiessenberg HD, Hart M, Bruins P, Voskuyl A, Daha MR, Hack CE.
    J Immunol Methods; 2005 Mar; 298(1-2):35-45. PubMed ID: 15847795
    [Abstract] [Full Text] [Related]

  • 24. Nitric oxide infusion alleviates cellular activation during preparation, leukofiltration and storage of platelets.
    Wong K, Li X.
    Transfus Apher Sci; 2004 Feb; 30(1):29-39. PubMed ID: 14746819
    [Abstract] [Full Text] [Related]

  • 25. Generation of the membrane attack complex during haemodialysis: impact of classical and alternative pathway components.
    Hauser AC, Derfler K, Stockenhuber F, Janata O, Balcke P.
    Clin Sci (Lond); 1990 Nov; 79(5):471-6. PubMed ID: 2174314
    [Abstract] [Full Text] [Related]

  • 26. Mechanism of complement-mediated activation of human blood platelets in vitro: comparison of normal and paroxysmal nocturnal hemoglobinuria platelets.
    Dixon RH, Rosse WF.
    J Clin Invest; 1977 Feb; 59(2):360-8. PubMed ID: 833281
    [Abstract] [Full Text] [Related]

  • 27. Absence of induction of IL-1 production in human monocytes by complement fragments.
    Arend WP, Massoni RJ, Niemann MA, Giclas PC.
    J Immunol; 1989 Jan 01; 142(1):173-8. PubMed ID: 2783323
    [Abstract] [Full Text] [Related]

  • 28. Complement activation in stored platelet concentrates.
    Miletic VD, Popovic O.
    Transfusion; 1993 Feb 01; 33(2):150-4. PubMed ID: 8430455
    [Abstract] [Full Text] [Related]

  • 29. Increased complement activation during platelet storage.
    Chen J, Losos M, Yang S, Li J, Wu H, Cataland S.
    Transfusion; 2017 Sep 01; 57(9):2182-2188. PubMed ID: 28671303
    [Abstract] [Full Text] [Related]

  • 30. Alternate complement pathway induction of aggregation and release of 5-hydroxytryptamine and adenosine diphosphate by rabbit platelets.
    Marney SR, Colley DG, Des Prez RM.
    J Immunol; 1975 Feb 01; 114(2 Pt 1):696-703. PubMed ID: 804512
    [Abstract] [Full Text] [Related]

  • 31. Synovial fluid levels of complement SC5b-9 and fragment Bb are elevated in patients with rheumatoid arthritis.
    Brodeur JP, Ruddy S, Schwartz LB, Moxley G.
    Arthritis Rheum; 1991 Dec 01; 34(12):1531-7. PubMed ID: 1747138
    [Abstract] [Full Text] [Related]

  • 32. Complement activation in human lymphoid germinal centres.
    Zwirner J, Felber E, Schmidt P, Riethmüller G, Feucht HE.
    Immunology; 1989 Feb 01; 66(2):270-7. PubMed ID: 2925226
    [Abstract] [Full Text] [Related]

  • 33. Complement component C2, inhibiting a latent serine protease in the classical pathway of complement activation.
    Halili MA, Ruiz-Gómez G, Le GT, Abbenante G, Fairlie DP.
    Biochemistry; 2009 Sep 08; 48(35):8466-72. PubMed ID: 19642650
    [Abstract] [Full Text] [Related]

  • 34. Complement activation in cancer patients undergoing immunotherapy with interleukin-2 (IL-2): binding of complement and C-reactive protein by IL-2-activated lymphocytes.
    Vachino G, Gelfand JA, Atkins MB, Tamerius JD, Demchak P, Mier JW.
    Blood; 1991 Nov 15; 78(10):2505-13. PubMed ID: 1824247
    [Abstract] [Full Text] [Related]

  • 35. The influence of classical pathway components during alternative pathway--modulated immune complex aggregation: the role of C1 INH.
    Gronski P, Bodenbender L, Kanzy EJ, Seiler FR.
    Behring Inst Mitt; 1984 Nov 15; (76):29-41. PubMed ID: 6335396
    [Abstract] [Full Text] [Related]

  • 36. Complement activation in diabetic ketoacidosis and its treatment.
    Jerath RS, Burek CL, Hoffman WH, Passmore GG.
    Clin Immunol; 2005 Jul 15; 116(1):11-7. PubMed ID: 15925827
    [Abstract] [Full Text] [Related]

  • 37. Distinctive regulation of contact activation by antithrombin and C1-inhibitor on activated platelets and material surfaces.
    Bäck J, Lang MH, Elgue G, Kalbitz M, Sanchez J, Ekdahl KN, Nilsson B.
    Biomaterials; 2009 Dec 15; 30(34):6573-80. PubMed ID: 19783299
    [Abstract] [Full Text] [Related]

  • 38. Interactions of the classical and alternate complement pathway with endotoxin lipopolysaccharide. Effect on platelets and blood coagulation.
    Kane MA, May JE, Frank MM.
    J Clin Invest; 1973 Feb 15; 52(2):370-6. PubMed ID: 4683877
    [Abstract] [Full Text] [Related]

  • 39. The analysis of the complement activation product SC5 b-9 is applicable in neonates in spite of their profound C9 deficiency.
    Høgåsen AK, Overlie I, Hansen TW, Abrahamsen TG, Finne PH, Høgåsen K.
    J Perinat Med; 2000 Feb 15; 28(1):39-48. PubMed ID: 10765513
    [Abstract] [Full Text] [Related]

  • 40. [Previous activation of platelets during storage: possible causes].
    Böck M, Heim MU, Schleuning M, Kempter B, Mempel W.
    Beitr Infusionsther Transfusionsmed; 1994 Feb 15; 32():81-3. PubMed ID: 9480163
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 27.